Getagraph.com logo
S&P 500
(0.04%) 5 189.55 points
Dow Jones
(0.50%) 39 077 points
Nasdaq
(-0.19%) 16 301 points
Oil
(1.03%) $79.19
Gas
(-1.18%) $2.18
Gold
(-0.32%) $2 316.70
Silver
(0.04%) $27.56
Platinum
(-0.12%) $987.20
USD/EUR
(0.13%) $0.931
USD/NOK
(0.09%) $10.91
USD/GBP
(0.11%) $0.800
USD/RUB
(0.19%) $91.62

リアルタイムの更新： Alembic Pharmaceuticals [APLLTD.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-08)

Expected move: +/- 2.87%

最終更新日時8 5月 2024 @ 18:59
25% discount on Stockinvest.us - Use code: Podcast

-1.70% INR 1 003.80

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations...

Stats
本日の出来高 41 416.00
平均出来高 141 818
時価総額 197.31B
EPS INR0 ( 2024-04-04 )
次の収益日 ( INR0 ) 2024-08-02
Last Dividend INR8.00 ( 2023-07-28 )
Next Dividend INR0 ( N/A )
P/E 33.45
ATR14 INR1.193 (0.12%)

ボリューム 相関

長: 0.10 (neutral)
短: 0.11 (neutral)
Signal:(41.64) Neutral

Alembic Pharmaceuticals 相関

10 最も正の相関
KRITIKA.NS0.931
ICICIPHARM.NS0.93
KOPRAN.NS0.929
NAVNETEDUL.NS0.923
MUTHOOTFIN.NS0.921
STAR.NS0.919
FAIRCHEMOR.NS0.912
KCP.NS0.908
AARTISURF.NS0.907
20MICRONS.NS0.907
10 最も負の相関
LTGILTBEES.NS-0.938
4THDIM.NS-0.936
RAJRILTD.NS-0.93
JSL.NS-0.893
ACI.NS-0.864
GNA.NS-0.858
SYMPHONY.NS-0.853
ISMTLTD.NS-0.849
DFMFOODS.NS-0.834
GTNIND.NS-0.817

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Alembic Pharmaceuticals 相関 - 通貨/商品

The country flag 0.25
( neutral )
The country flag 0.43
( neutral )
The country flag -0.39
( neutral )
The country flag 0.02
( neutral )
The country flag -0.46
( neutral )
The country flag -0.15
( neutral )

Alembic Pharmaceuticals 財務諸表

Annual 2022
収益: INR56.53B
総利益: INR39.44B (69.77 %)
EPS: INR17.40
FY 2022
収益: INR56.53B
総利益: INR39.44B (69.77 %)
EPS: INR17.40
FY 2022
収益: INR52.32B
総利益: INR35.09B (67.06 %)
EPS: INR26.50
FY 2021
収益: INR53.01B
総利益: INR37.80B (71.30 %)
EPS: INR60.81

Financial Reports:

No articles found.

Alembic Pharmaceuticals Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR10.00
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR8.00
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Alembic Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.28 - low (9.11%) | Divividend Growth Potential Score: 3.89 - Decrease likely (22.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR1.400 2012-07-31
Last Dividend INR8.00 2023-07-28
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 12 --
Total Paid Out INR62.90 --
Avg. Dividend % Per Year 0.84% --
Score 2.03 --
Div. Sustainability Score 3.28
Div.Growth Potential Score 3.89
Div. Directional Score 3.58 --
Next Divdend (Est)
 (2024-06-27)
INR8.06 Estimate 3.11 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.03
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR4.00 0.79%
2019 INR5.50 0.94%
2020 INR3.00 0.55%
2021 INR14.00 1.34%
2022 INR10.00 1.24%
2023 INR8.00 1.41%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHYAMMETL.NS Dividend Junior 2023-06-05 Semi-Annually 4 0.70%
MAXHEALTH.NS Dividend Junior 2023-09-08 Insufficient data to determine frequency 2 0.07%
GSPL.NS Dividend Junior 2023-09-01 Annually 19 0.81%
BANKINDIA.NS Dividend Junior 2023-06-20 Sporadic 23 1.34%
PRAJIND.NS Dividend Junior 2023-07-19 Annually 22 0.83%
KABRAEXTRU.NS Dividend Junior 2023-07-13 Annually 23 0.83%
DVL.NS Dividend Junior 2023-09-13 Annually 17 1.37%
ADANIENT.NS Dividend Junior 2023-07-06 Annually 23 0.08%
STARPAPER.NS Dividend Junior 2023-09-15 Sporadic 22 1.19%
MUNJALAU.NS Dividend Junior 2023-08-24 Sporadic 19 1.47%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.09651.5008.0710.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1341.5009.6310.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM10.281.0007.307.30[3 - 30]
operatingCashFlowPerShareTTM28.222.000.5951.189[0 - 30]
freeCashFlowPerShareTTM28.222.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.7111.0001.4841.484[0.2 - 0.8]
operatingProfitMarginTTM0.1001.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.28

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM33.551.0006.710[1 - 100]
returnOnEquityTTM0.1342.509.7610.00[0.1 - 1.5]
freeCashFlowPerShareTTM28.222.000.59510.00[0 - 30]
dividendYielPercentageTTM0.7941.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM28.222.000.5951.189[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.6411.5009.060[0.5 - 2]
operatingCashFlowSalesRatioTTM0.09071.000-0.2340[0.1 - 0.5]
Total Score3.89

Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。